# Simvastatin in Uveitis

> **NCT04183387** · PHASE2 · COMPLETED · sponsor: **Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology** · enrollment: 50 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Simvastatin 40mg

## Key facts

- **NCT ID:** NCT04183387
- **Lead sponsor:** Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04183387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04183387, "Simvastatin in Uveitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04183387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*